Cardiorenal syndrome: The emerging role of protein-bound uremic toxins

by Lekawanvijit S., Lekawanvijit S., Kompa A., Kompa A., Wang B., Kelly D., Krum H.
Published 2015

Protein-bound uremic toxins: A long overlooked culprit in cardiorenal syndrome

by Lekawanvijit S., Kompa A., Krum H.
Published 2017

Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats

by Tran L., Kompa A., Kemp W., Phrommintikul A., Wang B., Krum H.
Published 2017

Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: Implications for cardiorenal syndrome

by Liu S., Kompa A.R., Kumfu S., Nishijima F., Kelly D.J., Krum H., Wang B.H.
Published 2014

The uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction

by Lekawanvijit S., Kumfu S., Wang B.H., Manabe M., Nishijima F., Kelly D.J., Krum H., Kompa A.R.
Published 2014

Chronic urotensin II receptor antagonist treatment does not alter hypertrophy or fibrosis in a rat model of pressure-overload hypertrophy

by Kompa A.R., Wang B.H., Phrommintikul A., Ho P.Y., Kelly D.J., Behm D.J., Douglas S.A., Krum H.
Published 2014